307 filings
Page 3 of 16
8-K
w7qvr 6unl3kbi7
16 Dec 22
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
4:16pm
8-K
m2gp dpsx38fp
25 Oct 22
NeuroOne® Receives FDA 510(k) Clearance to Market its Evo® sEEG System for Less than 30 Day Use
9:19am
8-K
xoup7 8eppi0fztxyn
14 Sep 22
Regulation FD Disclosure
8:30am
8-K
dghx n9si
11 Aug 22
NeuroOne® Reports Third Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update
4:49pm
8-K
4e8h2sgl8j8owu9i23
3 Aug 22
NeuroOne® Announces $3.5 Million Accelerated Milestone Payment from Zimmer Biomet for Evo® sEEG Electrode
9:34am
8-K
0hv73kqhv522
2 Jun 22
NeuroOne® Issues Letter to Stockholders in Connection With 2022 Annual Meeting of Stockholders
4:05pm
8-K
x2fm8nut
16 May 22
NeuroOne Provides Evo® sEEG Update
4:38pm
8-K
4h45uo3
12 May 22
NeuroOne Reports Second Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update
4:17pm
8-K
zxj67rr74znpm3u86i22
25 Mar 22
Other Events
4:45pm
8-K
or2q3fd
14 Feb 22
NeuroOne Reports First Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update
4:10pm
8-K
zgl0px 4qir
4 Feb 22
Departure of Directors or Certain Officers
4:10pm
S-8
nxxa9pqiutoo76h1
28 Jan 22
Registration of securities for employees
4:15pm
8-K
uknqs58o
15 Dec 21
NeuroOne Reports Fourth Fiscal Quarter and Full Fiscal Year 2021
8:15am
S-8
1q75fbg44
23 Nov 21
Registration of securities for employees
4:15pm